Taiwan Liposome Ltd. (TLC)
NASDAQ: TLC
· Real-Time Price · USD
7.00
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Taiwan Liposome Revenue
Taiwan Liposome reported an annual revenue of $101.93M, reflecting a -51.26% growth. For the quarter ending June 30, 2021, Taiwan Liposome generated $160.18M in revenue.
Revenue (ttm)
101.93M
Revenue Growth
-51.26%
Price / Sales Ratio
47.99
Revenue / Employee
n/a
Employees
n/a
Market Cap
0
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2020 | 101.93M | -51.26% |
| Dec 31, 2019 | 209.14M | +235.57% |
| Dec 31, 2018 | 62.32M | +25.56% |
| Dec 31, 2017 | 49.63M | +19.10% |
| Dec 31, 2016 | 41.67M | -30.28% |
| Dec 31, 2015 | 59.77M | -37.69% |
| Dec 31, 2014 | 95.92M | -39.54% |
| Dec 31, 2013 | 158.64M | -34.08% |
| Dec 31, 2012 | 240.66M | +207.62% |
| Dec 31, 2011 | 78.23M | +113.45% |
| Dec 31, 2010 | 36.65M | +41.15% |
| Dec 31, 2009 | 25.96M | n/a |